Talk:Pharmaceutical industry

Archives (Index)

2015 2017 2018 2019 2021

This page is archived by ClueBot III.

This article was the subject of a Wiki Education Foundation-supported course assignment, between 12 January 2022 and 22 April 2022. Further details are available on the course page. Student editor(s): MikaylaRamsay (article contribs).

Wiki Education Foundation-supported course assignment

This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 October 2021 and 9 December 2021. Further details are available on the course page. Student editor(s): Tzc0725.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 02:18, 18 January 2022 (UTC)

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Yennnnhix.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:30, 17 January 2022 (UTC)

Controversies

The „Controversies“ section only talks about the situation in the US given that all numbers, sources,… are from the United States. Some of the information might be misleading for people from other countries with different regulations. I propose to add a disclaimer at the beginning of the section to say that this chapter shows the US side of things and might not represent the situation in other countries Akdns (talk) 07:58, 16 October 2022 (UTC)

Impact of Mergers and Acquisitions

I've added a brief section to the article that relates to this topic with only a single citation. I believe that this is a VERY under-appreciated aspect of the Pharma Industry and should be addressed in more depth and detail. Many (if not most) of the History sections of major pharma are replete with M&A activities, implicitly noting that these are significant events for the involved companies. I'm not a historian, so I'm not sure how to best address this, but I am SURE that this is not a 20th-21st Century phenomenon and it would be useful to see whether the impact in the "digital era" is greater than in the "industrial era", and specifically what that impact was. Thanks for considering this. --User:Ceyockey (talk to me) 04:01, 24 December 2022 (UTC) (P.S. I was at one time involved in M&A activities in the pharma that I'm currently employed by ... it is a non-trivial exercise that involves huge amounts of financial and human capital)

Opioid Crisis, Opium Wars & Pharma Industry Companies

As highlighted in the Big Pharma Conspiracy Topic, I'm working on that topic within scientific and research processes.

This article ignores the fact that very likely the (Big) Pharma Industry had a significant contribution to the First Wave of the Opioid Crisis by using aggressive marketing campaigns and corruption of the regulatory processes (e.g. implied by Prof Dr. Howard Koh and other scientists https://www.hsph.harvard.edu/news/features/what-led-to-the-opioid-crisis-and-how-to-fix-it/; https://journalofethics.ama-assn.org/article/how-fda-failures-contributed-opioid-crisis/2020-08) yet alone major news.

The companies consist of

- Purdue Pharma & Mundipharma

- Johnson & Johnson

- McKesson

- AmerisourceBergen

and many others acting as sub sellers (albeit not directly being involved in aggressive marketing but using other methods to defy the regulations in place by FDA and FTC).

Maybe that topic is too new but, but it should not be, as the Opium trade (not the Synthetic Second Wave) was also a reason why the old China was destroyed by the British Empire back then within the (forgotten) Opium Wars. HubertSchuf (talk) 16:32, 20 September 2024 (UTC)